CLASS ACTION SUIT against 5 drug companies • Patients diagnosed with NSF after being injected with contrast-agent • MRI • Never warned • side-effects
NATIONAL – 517 plaintiffs are suing “pharmaceutical companies that make certain dyes used for magnetic resonance imaging (MRI).” They were “diagnosed with nephrogenic systemic fibrosis (NSF)…after being injected with a contrast-agent made with gadolinium.” While “patients with healthy kidneys simply flush the gadolinium out,” those “with NSF…describe their skin turning wood-like, eventually cracking.” The FDA…